671 related articles for article (PubMed ID: 22613005)
1. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma.
Shih TC; Tien YJ; Wen CJ; Yeh TS; Yu MC; Huang CH; Lee YS; Yen TC; Hsieh SY
J Hepatol; 2012 Sep; 57(3):584-91. PubMed ID: 22613005
[TBL] [Abstract][Full Text] [Related]
2. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer.
Zhao WY; Wang Y; An ZJ; Shi CG; Zhu GA; Wang B; Lu MY; Pan CK; Chen P
Biochem Biophys Res Commun; 2013 Jun; 435(3):466-71. PubMed ID: 23673296
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).
Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X
Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365
[TBL] [Abstract][Full Text] [Related]
6. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway.
Yang X; Zhang XF; Lu X; Jia HL; Liang L; Dong QZ; Ye QH; Qin LX
Hepatology; 2014 May; 59(5):1874-85. PubMed ID: 24259426
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
[TBL] [Abstract][Full Text] [Related]
9. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J
J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766
[TBL] [Abstract][Full Text] [Related]
10. MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression.
Zhu K; Pan Q; Zhang X; Kong LQ; Fan J; Dai Z; Wang L; Yang XR; Hu J; Wan JL; Zhao YM; Tao ZH; Chai ZT; Zeng HY; Tang ZY; Sun HC; Zhou J
Carcinogenesis; 2013 Sep; 34(9):2071-9. PubMed ID: 23671131
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42.
Wang R; Zhao N; Li S; Fang JH; Chen MX; Yang J; Jia WH; Yuan Y; Zhuang SM
Hepatology; 2013 Aug; 58(2):642-53. PubMed ID: 23468064
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of HDGF Inhibits the Growth of Hepatocellular Carcinoma Cells In Vitro and In Vivo.
Enomoto H; Nakamura H; Liu W; Iwata Y; Nishikawa H; Takata R; Yoh K; Hasegawa K; Ishii A; Takashima T; Sakai Y; Aizawa N; Ikeda N; Iijima H; Nishiguchi S
Anticancer Res; 2015 Dec; 35(12):6475-9. PubMed ID: 26637859
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.
Su H; Yang JR; Xu T; Huang J; Xu L; Yuan Y; Zhuang SM
Cancer Res; 2009 Feb; 69(3):1135-42. PubMed ID: 19155302
[TBL] [Abstract][Full Text] [Related]
14. MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.
Law PT; Ching AK; Chan AW; Wong QW; Wong CK; To KF; Wong N
Carcinogenesis; 2012 Jun; 33(6):1134-41. PubMed ID: 22431718
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma.
Zhang T; Liu W; Zeng XC; Jiang N; Fu BS; Guo Y; Yi HM; Li H; Zhang Q; Chen WJ; Chen GH
Biomed Pharmacother; 2016 Dec; 84():583-591. PubMed ID: 27694002
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.
Xie Q; Chen X; Lu F; Zhang T; Hao M; Wang Y; Zhao J; McCrae MA; Zhuang H
Cancer; 2012 May; 118(9):2431-42. PubMed ID: 21989846
[TBL] [Abstract][Full Text] [Related]
17. Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145.
Jia Y; Liu H; Zhuang Q; Xu S; Yang Z; Li J; Lou J; Zhang W
Oncol Rep; 2012 Jun; 27(6):1865-72. PubMed ID: 22378186
[TBL] [Abstract][Full Text] [Related]
18. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
Liu X; Zhang A; Xiang J; Lv Y; Zhang X
Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
[TBL] [Abstract][Full Text] [Related]
19. Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.
Diao S; Zhang JF; Wang H; He ML; Lin MC; Chen Y; Kung HF
Proteomics; 2010 Oct; 10(20):3723-31. PubMed ID: 20859956
[TBL] [Abstract][Full Text] [Related]
20. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]